The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Guillain-Barre Syndrome Treatment Market Research Report 2025

Global Guillain-Barre Syndrome Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1714946

No of Pages : 82

Ask Your Query

Synopsis

Market Analysis and Insights: Global Guillain-Barre Syndrome Treatment Market
The global Guillain-Barre Syndrome Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Immunoglobulin Therapy accounting for % of the Guillain-Barre Syndrome Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.

China Guillain-Barre Syndrome Treatment market size is valued at US$ million in 2021, while the North America and Europe Guillain-Barre Syndrome Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Guillain-Barre Syndrome Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Guillain-Barre Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Guillain-Barre Syndrome Treatment market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Guillain-Barre Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Guillain-Barre Syndrome Treatment market.

Global Guillain-Barre Syndrome Treatment Scope and Market Size
Guillain-Barre Syndrome Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Guillain-Barre Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Immunoglobulin Therapy
  • Plasma Exchange (Plasmapheresis)

Segment by Application

  • Hospital
  • Clinic
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • CSL Limited
  • Grifols S A
  • Octapharma AG
  • Kedrion Biopharma Inc
  • Biotest AG
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guillain-Barre Syndrome Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immunoglobulin Therapy
1.2.3 Plasma Exchange (Plasmapheresis)
1.3 Market by Application
1.3.1 Global Guillain-Barre Syndrome Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Guillain-Barre Syndrome Treatment Market Perspective (2017-2028)
2.2 Guillain-Barre Syndrome Treatment Growth Trends by Region
2.2.1 Guillain-Barre Syndrome Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Guillain-Barre Syndrome Treatment Historic Market Size by Region (2017-2022)
2.2.3 Guillain-Barre Syndrome Treatment Forecasted Market Size by Region (2023-2028)
2.3 Guillain-Barre Syndrome Treatment Market Dynamics
2.3.1 Guillain-Barre Syndrome Treatment Industry Trends
2.3.2 Guillain-Barre Syndrome Treatment Market Drivers
2.3.3 Guillain-Barre Syndrome Treatment Market Challenges
2.3.4 Guillain-Barre Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Guillain-Barre Syndrome Treatment Players by Revenue
3.1.1 Global Top Guillain-Barre Syndrome Treatment Players by Revenue (2017-2022)
3.1.2 Global Guillain-Barre Syndrome Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Guillain-Barre Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Guillain-Barre Syndrome Treatment Revenue
3.4 Global Guillain-Barre Syndrome Treatment Market Concentration Ratio
3.4.1 Global Guillain-Barre Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guillain-Barre Syndrome Treatment Revenue in 2021
3.5 Guillain-Barre Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Guillain-Barre Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Guillain-Barre Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Guillain-Barre Syndrome Treatment Breakdown Data by Type
4.1 Global Guillain-Barre Syndrome Treatment Historic Market Size by Type (2017-2022)
4.2 Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Type (2023-2028)
5 Guillain-Barre Syndrome Treatment Breakdown Data by Application
5.1 Global Guillain-Barre Syndrome Treatment Historic Market Size by Application (2017-2022)
5.2 Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Guillain-Barre Syndrome Treatment Market Size (2017-2028)
6.2 North America Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022)
6.3 North America Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Guillain-Barre Syndrome Treatment Market Size (2017-2028)
7.2 Europe Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022)
7.3 Europe Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size (2017-2028)
8.2 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Guillain-Barre Syndrome Treatment Market Size (2017-2028)
9.2 Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022)
9.3 Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size (2017-2028)
10.2 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 CSL Limited
11.1.1 CSL Limited Company Detail
11.1.2 CSL Limited Business Overview
11.1.3 CSL Limited Guillain-Barre Syndrome Treatment Introduction
11.1.4 CSL Limited Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022)
11.1.5 CSL Limited Recent Development
11.2 Grifols S A
11.2.1 Grifols S A Company Detail
11.2.2 Grifols S A Business Overview
11.2.3 Grifols S A Guillain-Barre Syndrome Treatment Introduction
11.2.4 Grifols S A Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022)
11.2.5 Grifols S A Recent Development
11.3 Octapharma AG
11.3.1 Octapharma AG Company Detail
11.3.2 Octapharma AG Business Overview
11.3.3 Octapharma AG Guillain-Barre Syndrome Treatment Introduction
11.3.4 Octapharma AG Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022)
11.3.5 Octapharma AG Recent Development
11.4 Kedrion Biopharma Inc
11.4.1 Kedrion Biopharma Inc Company Detail
11.4.2 Kedrion Biopharma Inc Business Overview
11.4.3 Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Introduction
11.4.4 Kedrion Biopharma Inc Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022)
11.4.5 Kedrion Biopharma Inc Recent Development
11.5 Biotest AG
11.5.1 Biotest AG Company Detail
11.5.2 Biotest AG Business Overview
11.5.3 Biotest AG Guillain-Barre Syndrome Treatment Introduction
11.5.4 Biotest AG Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022)
11.5.5 Biotest AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Guillain-Barre Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunoglobulin Therapy
Table 3. Key Players of Plasma Exchange (Plasmapheresis)
Table 4. Global Guillain-Barre Syndrome Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Guillain-Barre Syndrome Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Guillain-Barre Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Guillain-Barre Syndrome Treatment Market Share by Region (2017-2022)
Table 8. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Guillain-Barre Syndrome Treatment Market Share by Region (2023-2028)
Table 10. Guillain-Barre Syndrome Treatment Market Trends
Table 11. Guillain-Barre Syndrome Treatment Market Drivers
Table 12. Guillain-Barre Syndrome Treatment Market Challenges
Table 13. Guillain-Barre Syndrome Treatment Market Restraints
Table 14. Global Guillain-Barre Syndrome Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Guillain-Barre Syndrome Treatment Market Share by Players (2017-2022)
Table 16. Global Top Guillain-Barre Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barre Syndrome Treatment as of 2021)
Table 17. Ranking of Global Top Guillain-Barre Syndrome Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Guillain-Barre Syndrome Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Guillain-Barre Syndrome Treatment Product Solution and Service
Table 21. Date of Enter into Guillain-Barre Syndrome Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Guillain-Barre Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Guillain-Barre Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. CSL Limited Company Detail
Table 42. CSL Limited Business Overview
Table 43. CSL Limited Guillain-Barre Syndrome Treatment Product
Table 44. CSL Limited Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 45. CSL Limited Recent Development
Table 46. Grifols S A Company Detail
Table 47. Grifols S A Business Overview
Table 48. Grifols S A Guillain-Barre Syndrome Treatment Product
Table 49. Grifols S A Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 50. Grifols S A Recent Development
Table 51. Octapharma AG Company Detail
Table 52. Octapharma AG Business Overview
Table 53. Octapharma AG Guillain-Barre Syndrome Treatment Product
Table 54. Octapharma AG Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 55. Octapharma AG Recent Development
Table 56. Kedrion Biopharma Inc Company Detail
Table 57. Kedrion Biopharma Inc Business Overview
Table 58. Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Product
Table 59. Kedrion Biopharma Inc Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 60. Kedrion Biopharma Inc Recent Development
Table 61. Biotest AG Company Detail
Table 62. Biotest AG Business Overview
Table 63. Biotest AG Guillain-Barre Syndrome Treatment Product
Table 64. Biotest AG Revenue in Guillain-Barre Syndrome Treatment Business (2017-2022) & (US$ Million)
Table 65. Biotest AG Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guillain-Barre Syndrome Treatment Market Share by Type: 2021 VS 2028
Figure 2. Immunoglobulin Therapy Features
Figure 3. Plasma Exchange (Plasmapheresis) Features
Figure 4. Global Guillain-Barre Syndrome Treatment Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Guillain-Barre Syndrome Treatment Report Years Considered
Figure 9. Global Guillain-Barre Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Guillain-Barre Syndrome Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Guillain-Barre Syndrome Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Guillain-Barre Syndrome Treatment Market Share by Players in 2021
Figure 13. Global Top Guillain-Barre Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barre Syndrome Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Guillain-Barre Syndrome Treatment Revenue in 2021
Figure 15. North America Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Guillain-Barre Syndrome Treatment Market Share by Country (2017-2028)
Figure 17. United States Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Guillain-Barre Syndrome Treatment Market Share by Country (2017-2028)
Figure 21. Germany Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Guillain-Barre Syndrome Treatment Market Share by Region (2017-2028)
Figure 29. China Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Guillain-Barre Syndrome Treatment Market Share by Country (2017-2028)
Figure 37. Mexico Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Guillain-Barre Syndrome Treatment Market Share by Country (2017-2028)
Figure 41. Turkey Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. CSL Limited Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2017-2022)
Figure 44. Grifols S A Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2017-2022)
Figure 45. Octapharma AG Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2017-2022)
Figure 46. Kedrion Biopharma Inc Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2017-2022)
Figure 47. Biotest AG Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2017-2022)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock